Stock Rating Upgrade
Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for Pacira BioSciences Inc (NASDAQ: PCRX) improved during the last several trading days. PCRX’s current Value Trend Rating is C and the prior Rating was D. Details supporting this higher rating are included in our next report.
Recent Price Action
Pacira BioSciences Inc (NASDAQ: PCRX) stock closed at $20.64 on 1/10/25 after a major increase of 11.1%. Moreover, exceptionally high trading volume at 224% of normal accompanied the advance. Relative to the market the stock has been extremely weak over the last nine months but has risen 9.6% during the last week.
Current PriceTarget Research Rating
Pacira BioSciences has a current Value Trend Rating of C (Neutral). This VT Rating improved in recent days from D previously. With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Pacira BioSciences has a good Appreciation Score of 80 but a poor Power Rating of 22, resulting in the Neutral Value Trend Rating.
Be the first to comment